Home > Specialists > Pancreatic Surgery > Dr. Xianjun Yu (虞先濬)
Home > Specialists > General Surgery > Dr. Xianjun Yu (虞先濬)
Specialty & Clinical Focus:
Pancreatic surgery specialist at Fudan University Shanghai Cancer Center in Shanghai, with a clinical focus on complex pancreatic tumor resection, robotic and laparoscopic pancreatic surgery, pancreatic neuroendocrine tumors, hepato-biliary surgery, and multidisciplinary management of advanced pancreatic cancer.
Professional Title & Qualifications:
Chief Physician
Professor & Doctoral Supervisor
President of Fudan University Shanghai Cancer Center
Director of Pancreatic Cancer Institute, Fudan University
FACS (Fellow of the American College of Surgeons)
Hospital & Department：
Fudan University Shanghai Cancer Center – Department of Pancreatic Surgery
(address: No. 270 Dong'an Road, Xuhui District, Shanghai, 200032)
Dr. Xianjun Yu (虞先濬) - Pancreatic Surgery Specialist
Personal Biography
Dr. Xianjun Yu is a Chief Physician, Professor and Doctoral Supervisor who serves as President of Fudan University Shanghai Cancer Center (FUSCC) and Director of its Department of Pancreatic Surgery. He also directs the Pancreatic Cancer Institute of Fudan University and the Shanghai Pancreatic Cancer Institute. Dr. Yu received his M.D. and Ph.D. from Fudan University and completed postdoctoral research and clinical training at Baylor College of Medicine and MD Anderson Cancer Center in the United States. In 2010, he established the Department of Pancreatic Surgery at FUSCC; under his leadership, the department led Shanghai in pancreatic malignancy surgery volume for eight consecutive years. His clinical and translational research focuses on pancreatic cancer surgery, surgical safety and comprehensive treatment strategies, and he has been invited to speak at international meetings including the International Association of Pancreatology (IAP) and the Japan Society of Clinical Oncology (JSCO).
Why Consult Dr. Xianjun Yu for Pancreatic Care?
Dr. Xianjun Yu leads the Department of Pancreatic Surgery at Fudan University Shanghai Cancer Center. Under his leadership, the department led Shanghai in pancreatic malignancy surgery volume for eight consecutive years. For international patients with pancreatic ductal adenocarcinoma, pancreatic neuroendocrine tumors, or cases requiring complex pancreatic or hepato-biliary surgery, his experience in high-volume surgery, minimally invasive techniques and multidisciplinary care makes him a relevant specialist to consider for a remote review before travel.
Dr. Yu is a Fellow of the American College of Surgeons (FACS) and has published more than 250 SCI papers. His training at Baylor College of Medicine and MD Anderson Cancer Center, together with research on pancreaticojejunostomy and individualized treatment strategies, adds useful context for complex case review. Preparing medical records, imaging, prior treatment history and key questions in advance can help his team provide a more focused opinion and recommendations before an international patient decides whether to pursue an in-person pathway in Shanghai.
Pre-Travel Case Review & Specialist Liaison
Making international healthcare decisions for serious pancreatic conditions is easier when the specialist has reviewed your records before you travel. MedBridgeNZ coordinates a remote specialist-review pathway with Dr. Xianjun Yu's hospital team, including medical-record preparation, translation coordination, client-authorized secure document transfer and appointment communication.
Dr. Yu's hospital team will review the submitted records and provide its clinical opinion, recommendations and responses to your questions. This pre-travel process helps you understand the specialist's perspective and plan any next-stage appointment or medical travel arrangements in Shanghai with greater clarity.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Xianjun Yu
Areas of Expertise
Radical Surgery for Pancreatic Tumors: Specializes in complex resections for pancreatic ductal adenocarcinoma and other malignancies.
Minimally Invasive Surgery: Expert in robotic and laparoscopic pancreatic surgery.
Pancreatic Neuroendocrine Tumors (pNETs): Comprehensive diagnosis and surgical management.
Hepato-biliary Surgery: Surgical treatment of liver and gallbladder tumors.
Comprehensive Treatment: Individualized multidisciplinary treatment (MDT) plans aimed at prolonging survival for advanced pancreatic cancer patients.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
23,300 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
President, Fudan University Shanghai Cancer Center, Shanghai, China (Current).
Director (Chair), Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center (2010 – Current).
Director, Pancreatic Cancer Institute, Fudan University / Shanghai Pancreatic Cancer Institute.
Postdoctoral Fellow / Visiting Scholar, MD Anderson Cancer Center & Baylor College of Medicine, USA.
Professor & Chief Physician, Fudan University Shanghai Cancer Center.
Education & Training
M.D. and Ph.D., Fudan University.
Postdoctoral research and clinical training, Baylor College of Medicine and MD Anderson Cancer Center, USA.
Awards & Honors
Distinguished Young Scholar, National Science Fund for Distinguished Young Scholars.
Chang Jiang Scholar, Ministry of Education of China.
National May 1st Labor Medal.
Leading Talent of Shanghai.
Shanghai Technology Elite.
Recipient, Special Government Allowance of the State Council.
Academic & Professional Memberships
Chairman, Committee of Pancreatic Cancer, Chinese Anti-Cancer Association (CACA).
Head, Chinese Study Group for Pancreatic Cancer (CSPAC).
Fellow, American College of Surgeons (FACS).
Standing Committee Member, Pancreatic Disease Committee, Chinese Medical Doctor Association.
Committee Member, Pancreatic Surgery Group, Surgery Branch of the Chinese Medical Association.
Research & Publications
High-Impact Publications: Published over 250 SCI papers in prestigious journals including Journal of Clinical Oncology, Gut, Annals of Surgery, Cell Research, and Clinical Cancer Research.
Surgical Innovations: Invented a new pancreaticojejunostomy technique to reduce postoperative pancreatic fistula rates, which has been cited in international clinical guidelines.
Clinical Strategy: Proposed individualized chemotherapy strategies based on stromal proportion in pancreatic cancer.
Patents: Holds 5 national patents for practical medical models and surgical instruments.
Funding: Principal investigator for multiple national-level projects, including key projects for the National Natural Science Foundation of China.
Selected Peer-Reviewed Publications
Lin Q, Zheng S, Yu X, et al. Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial. Cancer Commun (Lond). 2023;43(2):257–275. 👉 Read on PubMed (PMID: 36579790)
Qin R, Kendrick ML, Wolfgang CL, et al. International expert consensus on laparoscopic pancreaticoduodenectomy. Hepatobiliary Surg Nutr. 2020;9(4):464–483. 👉 Read on PubMed (PMID: 32832497)
Ji S, Cao L, Gao J, et al. Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups. Cancer Cell. 2025;43(4):776–796.e14. 👉 Read on PubMed (PMID: 40185092)
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Can Dr. Xianjun Yu review my pancreatic condition before I travel to China?
Dr. Yu's clinical focus includes complex pancreatic tumor surgery, pancreatic ductal adenocarcinoma, pancreatic neuroendocrine tumors, robotic and laparoscopic pancreatic surgery, and hepato-biliary procedures. For international patients, MedBridgeNZ can coordinate a pre-travel remote specialist review by preparing and transferring your authorized medical records and questions to his hospital team. The team will review the submitted information and provide its clinical opinion, recommendations and responses, helping you understand whether an in-person pathway in Shanghai is worth considering.
How can an international patient request a remote specialist review or hospital appointment with Dr. Yu?
MedBridgeNZ coordinates the administrative process for international patients seeking access to Dr. Yu at Fudan University Shanghai Cancer Center. We organize medical-record preparation, translation coordination, client-authorized document transfer and communication with the relevant hospital team. Depending on the pathway requested, this can include remote specialist-review coordination before travel and appointment request coordination for an in-person visit in Shanghai. For onsite visits, MedBridgeNZ follows up with the hospital based on the scheduling arrangements confirmed by FUSCC.
What support is available if I travel to Shanghai for surgery or further care?
If you decide to travel to Shanghai after the specialist review, MedBridgeNZ can coordinate the non-clinical logistics around your hospital visit. Support can include medical invitation or visa-document coordination, accommodation and travel planning, appointment communication, translation coordination, and non-clinical bilingual administrative support during hospital visits. These services are designed to make the cross-border process more organized from travel preparation through your hospital visits and related follow-up logistics.
Will MedBridgeNZ provide medical advice or Dr. Yu's clinical opinion?
MedBridgeNZ does not provide medical advice, diagnosis or treatment. Our role is medical concierge and logistics coordination: we prepare and transfer records with your authorization, coordinate translation and appointment communication, and help organize travel-related logistics. Any clinical opinion, recommendation or answer to your medical questions comes directly from Dr. Yu or the relevant licensed hospital team after they review the submitted information.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-care pathways in China, including access coordination with Dr. Xianjun Yu's team at Fudan University Shanghai Cancer Center in Shanghai. We help with remote specialist-review requests, medical-record preparation, translation coordination, appointment communication, medical invitation or visa-document coordination support, travel planning and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis or treatment. Hospital, specialist and other third-party medical or travel costs remain separate unless expressly stated in writing.